Seeking men and women aged 18 and older whose non-small cell lung cancer has come back or has grown after receiving immunotherapy treatment and who are not a candidate for other biomarker-matched treatment studies for a study of an investigational drug combination.
Participants in this study will be randomly assigned to get either the standard therapy or the investigational drug combination.
What we're hoping for
We are studying whether the investigational drug combination helps the immune system fight cancer and extend life for people whose non-small cell lung cancer has come back or has grown after receiving immunotherapy treatment
ClinicalTrials.gov Identifier: NCT05096663